SynthesisSurgical endoscopy2026
The efficacy of peroral endoscopic myotomy (POEM) for type III achalasia: a systematic review and meta-analysis.
Synthesis in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeroral endoscopic myotomy (POEM), a newly invented treatment for patients with achalasia, has achieved great success; however, for the rarest manometric subtype (type III), its efficacy remains unknown. We aimed to evaluate the efficacy of peroral endoscopic myotomy (POEM) for type III achalasia.
methodsA search was conducted in three databases (PubMed, Embase, and Cochrane Library) from inception to July 2025. The primary outcome was the pooled efficacy (defined by an Eckardt score ≤ 3 after the operation) at the longest available follow-up time. Secondary outcomes included the assessment of clinical efficacy over time, the impact of myotomy length on efficacy, and the evaluation of postoperative reflux.
resultsTwenty studies involving 606 patients with type III achalasia were included. The pooled efficacy of POEM for type III achalasia was 89.3% (95% CI: 85-93%), with moderate heterogeneity (I
conclusionsThis meta-analysis on POEM for type III achalasia showed a pooled success rate of 89.3%, with efficacy declining significantly from early (3-6 months) to long-term (24 months) follow-up. Myotomy length did not influence outcomes. Postprocedural GERD incidence assessed by symptoms, endoscopy, and pH monitoring were 18.7, 25.6, and 60.8%, supporting empirical PPI use and combined objective surveillance. Given the retrospective, small-sample evidence, POEM is effective in experienced centers but not yet a universal recommendation; randomized trials versus LHM with fundoplication are needed to establish it as first-line therapy.
Indexed as
Identifiers
42135495What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.